New Blog - Patient Focused Medicines Development

Recent Stories

Patient engagement is a mindset

·
At Roche, training is helping to make #patientengagement a central part of all discussions across the organisation, says Sanja Njegic, Dr. Pharm, Global Head of Patient Partnership and Séverine Wollenschneider...
+ Read more
Sort by
Sort by

More Stories

·

How COVID-19 changes clinical trials – for good

Pandemic sees clinical trials halted but some go virtual, benefiting patients, writes Danielle Barron With everything else upended by the coronavirus pandemic, it’s no surprise that clinical trials have...
·

The Patient Engagement Open Forum 2020

The third and by far the “biggest” Patient Engagement Open Forum to date kicked off on June  25th with over a 1,000 registered attendees across the whole program. This...
·

Protecting everyone’s interests: the RAPP project

The result of a truly collaborative project, a series of reasonable legal agreement templates, offers protection for both patients and pharmaceutical companies, explains Federica Castiglione of Novartis Achieving meaningful...
·

Involving patients in drug development – from the start

Patient engagement in preclinical research is a new phenomenon. Dr David Feldman, National Kidney Foundation, says a forthcoming PFMD How-To Guide will help connect researchers and patients in the...
·

Training can help to build capacity for patient engagement

Prof Benedikt Van Nieuwenhove, Managing Director of ECCRT, discusses the forthcoming PFMD ‘How-To Module for Capacity Building’ and how the COVID-19 pandemic is shifting attitudes to online...
X